Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 1:49 PM
Study NCT ID:
NCT07418567
Status:
COMPLETED
Last Update Posted:
2026-02-18
First Post:
2026-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Fasting Pilot Study for Long COVID
Sponsor:
Université de Sherbrooke
Organization:
Study Overview
Official Title:
A Prospective Pilot Study to Evaluate the Feasibility of Prolonged Fasting for the Treatment of Long COVID Patients
Status:
COMPLETED
Status Verified Date:
2026-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background Long COVID (LC) is a chronic multisystemic condition which substantially impact the quality of life. Despite the staggering burden of LC, there is still no effective treatment.
Because fasting promotes anti-inflammatory and antioxidant responses, which are involved in the pathophysiology of LC, we hypothesized that it might improve daily functioning and health-related quality of life in patients with LC.
The aim of this single center, one arm, prospective pilot clinical trial will be to assess the feasibility and acceptability of prolonged fasting for LC. The main questions aims to answers are;
1. Does in-home prolonged fasting (7 days) is feasible and acceptable for patients with LC
2. Is there a clinical benefit associated with fasting is LC patients
Participants (adults 18 year and older) will be asked to
1. Fast for 7 days
2. Have in-person visit at baseline (day 0) and at day 9 for checkups and tests
3. Answer difference questionnnaires about their perceived health during and after fasting
Because fasting promotes anti-inflammatory and antioxidant responses, which are involved in the pathophysiology of LC, we hypothesized that it might improve daily functioning and health-related quality of life in patients with LC.
The aim of this single center, one arm, prospective pilot clinical trial will be to assess the feasibility and acceptability of prolonged fasting for LC. The main questions aims to answers are;
1. Does in-home prolonged fasting (7 days) is feasible and acceptable for patients with LC
2. Is there a clinical benefit associated with fasting is LC patients
Participants (adults 18 year and older) will be asked to
1. Fast for 7 days
2. Have in-person visit at baseline (day 0) and at day 9 for checkups and tests
3. Answer difference questionnnaires about their perceived health during and after fasting
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| Programme PAFI 2024-2025 | OTHER | Centre de recherche du CIUSSSE-CHUS | View |